675 related articles for article (PubMed ID: 34893046)
1. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
[TBL] [Abstract][Full Text] [Related]
2. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
3. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G
EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829
[TBL] [Abstract][Full Text] [Related]
4. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
6. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
8. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.
Pasini FS; Zilberstein B; Snitcovsky I; Roela RA; Mangone FR; Ribeiro U; Nonogaki S; Brito GC; Callegari GD; Cecconello I; Alves VA; Eluf-Neto J; Chammas R; Federico MH
J Gastroenterol; 2014 Nov; 49(11):1453-66. PubMed ID: 24217965
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
Li C; Yang T; Yuan Y; Wen R; Yu H
Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
[TBL] [Abstract][Full Text] [Related]
10. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer.
Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H
Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505
[TBL] [Abstract][Full Text] [Related]
12. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
Front Immunol; 2021; 12():693314. PubMed ID: 34177954
[TBL] [Abstract][Full Text] [Related]
13. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
[TBL] [Abstract][Full Text] [Related]
14. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
15. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
17. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
18. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
19. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications.
Zhou YJ; Zhu GQ; Lu XF; Zheng KI; Wang QW; Chen JN; Zhang QW; Yan FR; Li XB
Cancer Immunol Immunother; 2020 Jun; 69(6):1057-1069. PubMed ID: 32100076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]